Our mission is to inspire, design, and advance solutions that improve the health and healthcare for patients with cancer. We do so by enhancing patient experience, improving patient outcomes, and increasing the efficiency and productivity of cancer care. We are passionate about catalyzing innovation with our partners.
Our Initiatives
We are change agents dedicated to designing, testing, scaling and disseminating innovations in cancer care.
Learn more
We are worldwide experts in employing financial and non-financial interventions to nudge patient and clinician behavior in cancer care, informed by lessons from health economics and behavioral economics.
Learn more
We aim to drive high-value cancer care by designing, testing, scaling and evaluating payment models that enhance affordability, access and innovation.
Learn more
We employ a health equity lens across our work, examining and addressing socioeconomic, racial, and ethnic disparities and other systemic barriers to accessing healthcare.
Learn More
We integrate augmented and artificial intelligence into our solutions to predict health outcomes, support decision making, challenge bias, and enhance health equity.
Augmented & Artificial Intelligence
04.23.2021
With HPV testing increasingly becoming the recommended form of screening for cervical cancer, this study explored the impact of messaging on public knowledge and uptake of cervical cancer screening.
04.07.2021
These policy options are offered to create liability while balance balancing innovation and patient safety when it comes to the use of AI and machine learning.
10.16.2020
Electronic nudges, triggered by a machine-learning algorithm that flags patients at greater mortality risk, increased conversations on end-of-life goals.
04.30.2021
This documentary series by Medscape highlights PC3I-led Cancer Care @ Home initiative, which has allowed patients to receive treatment at home safely, comfortably, and surrounded by family.
04.29.2021
An analysis of clinical data has provided insight regarding treatment options for patients with non-small cell lung cancer.
04.23.2021
Proton therapy has been approved by the FDA as a form of cancer treatment for over 30 years. But does it provide any added benefit over photon therapy?